Get the Stockscreener App
23.77
2.50%
0.58
After Hours:
23.81
0.04
+0.17%
Liquidia Corp stock is traded at $23.77, with a volume of 1.64M.
It is up +2.50% in the last 24 hours and down -8.54% over the past month.
Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also generates revenue from the sale of Treprostinil Injection through an agreement between its subsidiary and the manufacturer.
See More
Previous Close:
$23.19
Open:
$23.51
24h Volume:
1.64M
Relative Volume:
0.61
Market Cap:
$2.05B
Revenue:
$17.49M
Net Income/Loss:
$-78.50M
P/E Ratio:
-19.81
EPS:
-1.2
Net Cash Flow:
$-52.85M
1W Performance:
+3.98%
1M Performance:
-8.54%
6M Performance:
+76.47%
1Y Performance:
+114.43%
1-Day Range:
$23.07
$24.10
1-Week Range:
$22.60
$25.12
52-Week Range:
$9.71
$29.94
Liquidia Corp Stock (LQDA) Company Profile
Name
Liquidia Corp
Sector
Industry
Phone
919.328.4400
Address
419 DAVIS DRIVE, SUITE 100, MORRISVILLE, NC
Compare LQDA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LQDA
Liquidia Corp
|
23.77 | 2.00B | 17.49M | -78.50M | -52.85M | -1.20 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.37 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.95 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
557.73 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
799.56 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
327.03 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Liquidia Corp Stock (LQDA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-15-25 | Resumed | Jefferies | Buy |
| May-19-25 | Downgrade | Oppenheimer | Perform → Underperform |
| Dec-20-24 | Initiated | Wells Fargo | Overweight |
| Oct-16-24 | Initiated | Scotiabank | Sector Outperform |
| Aug-19-24 | Upgrade | Raymond James | Outperform → Strong Buy |
| Aug-16-24 | Initiated | Raymond James | Outperform |
| Jun-25-24 | Initiated | Oppenheimer | Perform |
| Jan-05-24 | Reiterated | Needham | Buy |
| Sep-19-22 | Resumed | Wedbush | Underperform |
| Sep-01-22 | Downgrade | Wedbush | Neutral → Underperform |
| Jul-22-22 | Initiated | Ladenburg Thalmann | Buy |
| May-31-22 | Initiated | BTIG Research | Buy |
| May-26-22 | Initiated | BofA Securities | Buy |
| Dec-04-20 | Initiated | H.C. Wainwright | Buy |
| Nov-20-20 | Downgrade | Wedbush | Outperform → Neutral |
| Nov-08-18 | Resumed | Jefferies | Buy |
| Sep-05-18 | Initiated | Wedbush | Outperform |
| Aug-20-18 | Initiated | Jefferies | Buy |
| Aug-20-18 | Initiated | Needham | Buy |
View All
Liquidia Corp Stock (LQDA) Latest News
What sentiment indicators say about Liquidia Corporation stockFed Meeting & Daily Risk Controlled Trade Plans - newser.com
Is Liquidia Corporation showing signs of accumulationFed Meeting & Technical Pattern Alert System - newser.com
Real time alert setup for Liquidia Corporation performanceQuarterly Trade Review & AI Based Buy and Sell Signals - newser.com
Liquidia Technologies (NASDAQ:LQDA) Receives Sell (D-) Rating from Weiss Ratings - MarketBeat
Bank of America Securities Sticks to Their Buy Rating for Liquidia Technologies (LQDA) - The Globe and Mail
Liquidia Corporation’s volatility index tracking explained2025 Market Overview & Weekly High Return Opportunities - newser.com
Liquidia Corporation to Host R&D Day in New York City on October 28, 2025 - The Manila Times
Oct. 28 R&D Day — Liquidia to present L606 sustained‑release and YUTREPIA clinical update; webcast - Stock Titan
HC Wainwright Reaffirms Buy Rating for Liquidia Technologies (NASDAQ:LQDA) - MarketBeat
LQDA: HC Wainwright Reiterates Buy Rating with $35 PT | LQDA Sto - GuruFocus
What machine learning models say about Liquidia CorporationJuly 2025 Opening Moves & Stock Market Timing Techniques - newser.com
Can Liquidia Corporation (LT4) stock ride next bull market cycleJuly 2025 Macro Moves & High Accuracy Investment Signals - newser.com
Liquidia (LQDA): Evaluating Valuation After Positive Tyvaso Results Shift Pulmonary Treatment Landscape - simplywall.st
Liquidia Corporation Stock Analysis and ForecastVolatility Trading Techniques & Stocks to Buy Before Earnings Season - earlytimes.in
Analyzing drawdowns of Liquidia Corporation with statistical tools2025 Support & Resistance & Safe Entry Trade Signal Reports - newser.com
Will Liquidia Corporation rebound enough to break evenJuly 2025 Selloffs & Short-Term High Return Ideas - newser.com
Combining machine learning predictions for Liquidia CorporationDividend Hike & Smart Money Movement Alerts - newser.com
Is Liquidia Corporation (LT4) stock a top dividend aristocrat candidateJuly 2025 Analyst Calls & Daily Stock Trend Watchlist - newser.com
Will Liquidia Corporation stock outperform value stocksPortfolio Update Report & Free Expert Verified Stock Movement Alerts - newser.com
Will Liquidia Corporation (LT4) stock sustain uptrend momentumWeekly Profit Analysis & Daily Chart Pattern Signal Reports - newser.com
UTC, Liquidia Clash on Xarelto Patent Ruling’s Tyvaso Impact - Bloomberg Law News
Is Liquidia Corporation (LT4) stock prepared for digital transitionQuarterly Market Summary & High Accuracy Swing Entry Alerts - newser.com
3 Growth Companies With High Insider Ownership Seeing Up To 63% Revenue Growth - simplywall.st
What’s the recovery path for long term holders of Liquidia CorporationWeekly Market Report & AI Powered Buy and Sell Recommendations - newser.com
Breaking PH-ILD Research: Liquidia's LIQ861 16-Week Trial Data to be Revealed at Major CHEST Conference - Stock Titan
Multi asset correlation models including Liquidia CorporationJuly 2025 Update & Fast Gain Stock Trading Tips - newser.com
Liquidia to Present Clinical Data from ASCENT Trial at the CHEST 2025 Annual Meeting - Yahoo Finance
Is Liquidia Corporation stock attractive for income investors2025 Major Catalysts & Community Verified Swing Trade Signals - newser.com
Liquidia Corporation (LQDA) Presents Strategic Overview at Well Fargo’s Annual Healthcare Conference 2025 - Yahoo Finance
Is it a Wise Move to Buy Liquidia Corp. (LQDA) Shares? - Yahoo Finance
Institutional investors in Liquidia Corporation (NASDAQ:LQDA) lost 8.5% last week but have reaped the benefits of longer-term growth - Yahoo Finance
Insider Selling: Liquidia Technologies (NASDAQ:LQDA) Director Sells 45,524 Shares of Stock - MarketBeat
Exit strategy if you’re trapped in Liquidia CorporationMarket Sentiment Report & Reliable Price Action Trade Plans - newser.com
Should you hold or exit Liquidia Corporation nowWeekly Stock Recap & Reliable Intraday Trade Alerts - newser.com
How to monitor Liquidia Corporation with trend dashboards2025 EndofYear Setup & High Accuracy Trade Alerts - newser.com
Predicting Liquidia Corporation trend using moving averagesJuly 2025 Opening Moves & Free Weekly Watchlist of Top Performers - newser.com
Historical volatility pattern of Liquidia Corporation visualizedTrade Analysis Report & Short-Term Trading Opportunity Alerts - newser.com
Tools to monitor Liquidia Corporation recovery probabilityQuarterly Portfolio Report & Expert Approved Momentum Trade Ideas - newser.com
Sentiment Watch: Can WideOpenWest Inc. sustain earnings growthAnalyst Upgrade & Free Technical Confirmation Trade Alerts - خودرو بانک
Liquidia Corporation (LQDA): A Bull Case Theory - Yahoo Finance
Risk Hedge: Does Liquidia Corporation have strong EBITDA marginsVolume Spike & Daily Chart Pattern Signals - khodrobank.com
Bluefin Capital Management LLC Invests $250,000 in Liquidia Technologies, Inc. $LQDA - MarketBeat
Liquidia Announces Poster Presentations at the Pulmonary Hypertension Professional Association (PHPN) Symposium - The Manila Times
Liquidia Corporation to Present New Data on LIQ861 at Pulmonary Hypertension Professional Association Symposium - Quiver Quantitative
Breaking PH-ILD Treatment Data: Liquidia's YUTREPIA Shows New Safety Results in ASCENT Trial at PHPN - Stock Titan
Boothbay Fund Management LLC Boosts Holdings in Liquidia Technologies, Inc. $LQDA - MarketBeat
Jefferies Highlights Yutrepia’s Market Edge in Supporting a Buy on Liquidia (LQDA) - MSN
Liquidia Corp Stock (LQDA) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):